Aldeyra Therapeutics Receives Orphan Designation from the European Medicines Agency for ADX-2191 for the Treatment of Primary Large B-Cell Lymphomas of Immune-Privileged Sites, including Primary Vitreoretinal Lymphoma
Compugen - Compugen to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Pasithea Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Pasithea Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Vanda Pharmaceuticals Announces FDA Granted Orphan Drug Designation for VGT-1849B, a Novel and Selective Candidate for the Treatment of Polycythemia Vera
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
Tonix Pharmaceuticals to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2025
MindMed to Participate in September Investor Conferences
Cibus Enters into Agreement with the Latin American Rice Hybrid Consortium to Provide Cibus’ Herbicide Tolerance Trait
Passage Bio, Inc. - Passage Bio to Participate in H.C. Wainwright 27th Annual Global Investment Conference
Cartesian Therapeutics to Participate in Upcoming Investor Conferences
Tilray Medical Expands Presence in Germany with Introduction of New Good Supply Medical Cannabis Strains
Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025
Akero Therapeutics to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
Compugen to Present at the H.C. Wainwright 27th Annual Global Investment Conference